Literature DB >> 20416139

Chronic cyanosis and vascular function: implications for patients with cyanotic congenital heart disease.

Rachael L Cordina1, David S Celermajer.   

Abstract

In patients with cyanotic congenital heart disease, chronic hypoxaemia leads to important changes in blood vessel function and structure. Some of these alterations are maladaptive and probably contribute to impaired cardiopulmonary performance and an increased incidence of thrombotic and embolic events. Recent evidence suggests that deranged endothelial function, a sequel of chronic cyanosis, could be an important factor in the pathogenesis of cyanosis-associated cardiovascular risk. In this article, we discuss the physiological and mechanical consequences of compensatory erythrocytosis and possible pathophysiological mechanisms of vascular dysfunction in chronic cyanosis.

Entities:  

Mesh:

Year:  2010        PMID: 20416139     DOI: 10.1017/S1047951110000466

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  8 in total

Review 1.  Hypoxia signaling in human health and diseases: implications and prospects for therapeutics.

Authors:  Zhen Luo; Mingfu Tian; Ge Yang; Qiaoru Tan; Yubing Chen; Geng Li; Qiwei Zhang; Yongkui Li; Pin Wan; Jianguo Wu
Journal:  Signal Transduct Target Ther       Date:  2022-07-07

2.  miR-375-3p contributes to hypoxia-induced apoptosis by targeting forkhead box P1 (FOXP1) and Bcl2 like protein 2 (Bcl2l2) in rat cardiomyocyte h9c2 cells.

Authors:  Yuefan Li; Xiaofei Li; Ling Wang; Na Han; Gang Yin
Journal:  Biotechnol Lett       Date:  2020-10-30       Impact factor: 2.461

3.  Brain volumetric, regional cortical thickness and radiographic findings in adults with cyanotic congenital heart disease.

Authors:  Rachael Cordina; Stuart Grieve; Michael Barnett; Jim Lagopoulos; Nathan Malitz; David S Celermajer
Journal:  Neuroimage Clin       Date:  2014-01-04       Impact factor: 4.881

4.  The effects of corrective surgery on endothelial biomarkers and anthropometric data in children with congenital heart disease.

Authors:  Hung-Tao Chung; Yu-Sheng Chang; Sui-Ling Liao; Shen-Hao Lai
Journal:  J Int Med Res       Date:  2017-01-01       Impact factor: 1.671

5.  MicroRNA-219-5p participates in cyanotic congenital heart disease progression by regulating cardiomyocyte apoptosis.

Authors:  Chuanxian Hu; Su Huang; Fafu Wu; Hui Ding
Journal:  Exp Ther Med       Date:  2020-11-11       Impact factor: 2.447

6.  Endothelial dysfunction and atherosclerosis in children with irreversible pulmonary hypertension due to congenital heart disease.

Authors:  Murat Ciftel; Ayse Simşek; Ozlem Turan; Firat Kardelen; Gayaz Akçurin; Halil Ertuğ
Journal:  Ann Pediatr Cardiol       Date:  2012-07

Review 7.  Chronic kidney disease in congenital heart disease patients: a narrative review of evidence.

Authors:  Catherine Morgan; Mohammed Al-Aklabi; Gonzalo Garcia Guerra
Journal:  Can J Kidney Health Dis       Date:  2015-08-11

8.  Retinal microvasculature impairment in patients with congenital heart disease investigated by optical coherence tomography angiography.

Authors:  Cong Li; Pingting Zhong; Haiyun Yuan; Xinran Dong; Qingsheng Peng; Manqing Huang; Qiaowei Wu; Baoyi Liu; Minghui Xu; Yu Kuang; Xiaomin Zeng; Yu Xiao; Ying Fang; Honghua Yu; Xiaohong Yang
Journal:  Clin Exp Ophthalmol       Date:  2020-09-16       Impact factor: 4.207

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.